USPTO serial 79266962
YUYU
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 17, 2024
- Examiner
- DUBOIS, SUSAN L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with YUYU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard Y. Kim
Richard Y. Kim SNELL & WILMER L.L.P.One East Washington Street, Suite 2700Phoenix, AZ 85004-2556United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated multi-functional shampoo; non-medicated anti-aging cosmetic preparations; make-up; hair dyes; beauty soap; non-medicated moisturizing skin creams; non-medicated toiletry preparations; bleaching preparations for laundry use; skin creams; non-medicated cosmetic preparations for the treatment for atopy prone skin; essential oils for flavoring beverages; non-medicated soaps for personal use; cosmetic sun-protecting preparations; non-medicated anti-wrinkle creams; non-medicated wrinkle removing skin care preparations; dentifrices; cosmetic preparations for skin renewal; non-medicated skin care preparations for treating skin trouble; non-medicated skin whitening preparations; perfumery; perfumes; hair rinses; beauty masks; mask pack for cosmetic purposes; lotions for cosmetic purposes; cosmetics | ACTIVE | — |
| 005 | Pharmaceutical agents affecting sensory organs; air deodorizing preparations; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; vaccines; bandages for dressings; vitamin preparations; oxygen baths preparations for medical use; crude medicines, namely, hydrogen peroxide, glycerin, sodium salts, roots, enzymes, medicinal oils that are not essential oils, lecithin, appetite suppressants, amino acids, alkaloids in the nature of opium alkaloid preparations and alkaloid pain relief medication, bark in the nature of myrobalan, condurango, croton and angostura bark for medical and pharmaceutical purposes, herbs, mineral waters, gases, camphor oil, gelatin capsules sold empty for pharmaceuticals, diagnostic preparations, medicinal teas, slimming teas, medicinal teas, chewing gum, potassium salts, quinine, herbal tinctures, glucose, herb teas, blood, hormones, enzymes, pharmaceutical mint, pharmaceutical digestives, aldehydes alcohol; fish meal for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; ethers for pharmaceutical purposes; medicated ointments for pharmaceutical purposes; iodine for pharmaceutical purposes; iodides for pharmaceutical purposes; flowers of sulfur for pharmaceutical purposes; decoctions of medicinal herb for pharmaceutical purposes; thymol for pharmaceutical purposes; pectin for pharmaceutical purposes; pepsins for pharmaceutical purposes; peptones for pharmaceutical purposes; ginseng capsules for medical purposes; contact lens cleaning preparations; solutions for use with contact lenses; implants comprising living tissue; anti-inflammatory preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; dietetic food supplements; dietary and nutritional supplements; nervines, namely, nerve calming preparation and pharmaceutical preparations acting on the central nervous system; allergy medications; medicated soap; filled first-aid boxes; digestives for pharmaceutical purposes; alcohol for pharmaceutical purposes; food for babies except lacteal flour for babies; pharmaceutical agents for epidermis; biological preparations for medical or veterinary purposes, drugs for medicinal purposes and pharmaceuticals, namely, pharmaceutical preparations for the treatment or prevention of ophthalmic, dermatological, urological, hematological, bone, skeletal, respiratory, endocrinological, circulatory, gastroenterological, hormonal, diabetic, muscular, rheumatic, immune system, ocular, psychiatric, cognitive, mood, infectious, oncological, gynecological, sexual, pediatric disorders; pharmaceutical preparations for the preventing and treating of diabetes, coughs, colds, influenza, headaches; pharmaceutical preparation for the treatment of wounds and trauma; medicinal preparations, namely, analgesics, anti-depressants, antipsychotics, antihistamines, anti-infectives, anti-hypertensives, anti-dyslipidemia, anti-bacterial soaps, anti-bacterial cleaners, anti-bacterial pharmaceutics, antidiarrheals, and medicines for the treatment of +GERD/NERD conditions, ulcers, diarrhea, constipation, and dyspepsia; anticoagulants; medicinal preparations, namely, antiviral and anti-retroviral preparations for the treatment of viral brain diseases; medicinal preparations, namely, anti-cancer preparations; medicinal preparations, namely, medicated soaps, lotions and creams for the skin and hair, namely, medicated acne lotion, medicated body moisturizing lotion, medicated lotion for eczema and seborrheic dermatitis, medicated hair shampoo and hair scalp lotion, and medicated anti-dandruff lotion; medicinal preparations, namely, cough suppressants; medicinal preparations, namely, preparations for the treatment of gout; medicinal preparations, namely, preparations for cessation of smoking; medicinal preparations for the treatment, of genitourinary diseases and disorders, urological diseases, namely, benign prostatic hyperplasia and prostate enlargement, urinary incontinence, infertility, erectile dysfunction, sexually transmitted diseases, premature ejaculation, and anemia; medicinal preparations for the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; medicinal preparations for the treatment of androgenetic alopecia and alopecia areata; medicinal preparations for the treatment of CNS disorders, cognitive disorders, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, seizures, Huntington's disease, multiple sclerosis, stroke recovery, migraine, vertigo, tinnitus, and brain dysfunction; medicinal preparations for the treatment of pain from burns, hemolytic diseases and disorders, peripheral circulatory disturbance, intermittent claudication, and neuropathic pain; medicinal preparations for the treatment of chronic pain, obesity, inflammatory bowel diseases, inflammatory connective tissue diseases, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome, viral diseases and disorders, namely, herpes, hepatitis, substance abuse disorders, namely, alcoholism and drug addiction, varicose veins, osteoporosis, postmenopausal osteoporosis, sarcopenia, muscle spasm, arthritis, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, dysmenorrhea, bruise, lumbar pain, secondary hyperparathyroidism, hypocalcemia, neuralgia, myotonia yeast infections, pulmonary disorders, sleep disorders, namely, insomnia, eye disorders, namely, macular degeneration, dry eye, inflammatory eye diseases, namely, conjunctivitis, iritis, keratitis, Uveitis and rare eye diseases caused by inflammation; biosimilars and biological preparations and monoclonal antibodies for treatment of cancer, tumors, immunologic disorders, autoimmune diseases, bones diseases, osteoporosis, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; medicinal hair growth preparations; solutions for medical use in washing the nasal passages; adhesive bands for medical purposes; nutritional supplements, namely, tonics and alteratives for medical purposes; pharmaceutical preparations acting on the central nervous system; decongestant nasal sprays; materials for dental fillings and for stopping purposes, dental wax; sea water for medicinal bathing; hemostatic pencils; antibiotic preparations | ACTIVE | — |
| 010 | Physiotherapy apparatus, namely, foam rollers, weights and resistance bands; suture materials; hot air blowers for therapeutic use, namely, electric heating devices for curative treatment; artificial vascular grafts for surgical use; medical apparatus and instruments, namely, syringes, inhalers, injections, lenses, defribillator/monitor, CPR/chest compression device, patient thermal regulating/cooling system, Ear, nose and throat (ENT) diagnostic and therapy equipment, endoscopes, microscopes, dosage planning devices, health monitoring devices comprised of monitors, sensors, and detectors that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, ophthalmic, urological and respiratory diseases; protective devices and protective screens for protecting against exposure, face shields for medical use, protective lead gloves for medical use, medical safety glasses; biometric medical scanners for health check and diagnosis, medical instruments and apparatus for the treatment of respiratory disorders, asthma, allergies and allergic emergencies; medical devices, namely, wireless patient monitors and sensors for monitoring the vital signs of patients; transdermal drug delivery patches sold without medication for the transdermal delivery of pharmaceuticals; vaporizers for medical purposes; oxygen inhalers for medical purposes sold empty; thread for medical use; aerosol dispensers for medical purposes; vacuum pumps for medical purposes; respiratory masks for medical purposes; endoprostheses; apparatus for artificial respiration; orthopaedic articles, namely, walkers, supports and braces; appliances for washing body cavities; filling instruments for dental purposes; portable oxygen concentrators for medical purposes sold empty; oxygen inhalers for medical purposes sold empty | ACTIVE | — |
| 030 | Fruit teas; tea based on the substances extracted from the plant leaves; wheat germ for human consumption; ginseng tea; tea extracts; tea; tea-based beverages; processed tea leaves; spices | ACTIVE | — |
| 035 | Retail store services and distributorships in the field of health supplement food mainly based on processed cereals; retail store services and distributorships in the field of false hair; retail store services and distributorships in the field of health supplement food based on dried fish and shellfish; marketing services; retail store services and distributorships in the field of the field of jewelry and precious metals; retail store services and distributorships in the field of jewelry; retail store services and distributorships in the field of non-alcoholic beverages; data provision for commercial retail purposes, namely, providing business and commercial information; demonstration of goods; retail store services and distributorships in the field of fish-based foodstuffs; import-export agency services; conducting market surveys; retail store services and distributorships in the field of processed algae for human consumption; distributorships in the field of edible eggs; retail store services and distributorships in the field of food products made from fish and shellfish; retail store services and distributorships in the field of food products made from oil and fat; retail store services and distributorships in the field of drinking water; retail store services and distributorships in the field of medical apparatus and instruments; retail store services and distributorships in the field of pharmaceuticals; computerized business information retrieval for others, namely, computer-assisted business information and research services; retail store services and distributorships in the field of nutraceutical preparations for therapeutic or medical purposes; retail store services and distributorships in the field of health food supplements for persons with special dietary requirements | ACTIVE | — |
| 042 | Biotechnology research; medical research in the field of crude medicines; bacteriological research and analysis; technical consultancy in relation to research services relating to foods and dietary supplements; drug discovery services; research and development of new products; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; pharmaceutical products development; consultancy relating to pharmaceutical research and development for others; research on the subject of pharmaceuticals; conducting clinical testing of medicines for others; research and development of medical apparatus and instruments for others; medical product testing for others; research for medical products; medical research; research in the field of hair care; cosmetics development services for others | ACTIVE | — |
| 044 | Medical and health services, namely, the screening of DNA and providing genetic testing for medical purposes; health care; physical therapy; medical consultancy and information services relating to the administration of biopharmaceutical products; medical services for the care of the skin; dietetic advisory services; pharmacy services, namely, the dispensing of pharmaceuticals; medical consultancy and information services relating to the administration of pharmaceutical products; providing medical pharmacy advice; rental of medical and health care equipment; medical assistance; health care consultancy services, namely, providing medical information; medical consultancy services for selecting appropriate medicines; health consulting, namely, providing information relating to medical products; beauty salons for hair loss treatment; skin care salons; skin beauty salons; vascular screening | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Yuyu Pharma, Inc.
- Other trademarks owned by Yuyu Pharma, Inc.
- Other trademarks owned by Yuyu Pharma, Inc.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 030
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named YUYU
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 14, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 22, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 22, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 17, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 2, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 2, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 12, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 11, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 11, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 28, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 29, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 29, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 9, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 13, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 7, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 1, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 11, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 11, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 11, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 11, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 6, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 17, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 6, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 6, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 6, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 30, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 4, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 4, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 4, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 4, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 4, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 4, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 23, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 23, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 3, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 2, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 26, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 3, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 3, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 20, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 17, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 16, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 12, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |